These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 945050)

  • 1. Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
    Maj J; Sowińska H; Baran L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):197-203. PubMed ID: 945050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action of compound WA-335 on the central nervous system.
    Maj J; Baran L; Sowińska H; Gancarczyk L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy.
    Maj J; Mogilnicka E; Przewlocka B
    Pharmacol Biochem Behav; 1975; 3(1):25-7. PubMed ID: 1168927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats.
    Sarnek J; Baran L
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):511-6. PubMed ID: 1172422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of theophylline and caffeine on neuroleptic-induced catalepsy.
    Maj J; Rawlów A; Sarnek J
    Pol J Pharmacol Pharm; 1976; 28(6):571-8. PubMed ID: 1034921
    [No Abstract]   [Full Text] [Related]  

  • 6. FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
    Singh A; Naidu PS; Kulkarni SK
    Indian J Exp Biol; 2003 Nov; 41(11):1264-8. PubMed ID: 15332494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1975 Nov; 25(11):1723-37. PubMed ID: 1049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central action of WA-335-BS, a substance with peripheral antiserotonin and antihistaminic activity].
    Kähling J; Ziegler H; Ballhause H
    Arzneimittelforschung; 1975 Nov; 25(11):1737-44. PubMed ID: 1050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antihistamine drugs on the neuroleptic-induced catalepsy.
    Pawłowski L; Sidorowicz L
    Pol J Pharmacol Pharm; 1978; 30(5):665-73. PubMed ID: 35784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticataleptic action of psychostimulating drugs and serotonin in brain.
    Malec D; Langwiński R
    Acta Physiol Pol; 1979; 30(5-6):589-95. PubMed ID: 161138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the anticataleptic action of cyproheptadine.
    Maj J; Sarnek J; Klimek V; Rawlów A
    Pharmacol Biochem Behav; 1976 Aug; 5(2):201-5. PubMed ID: 1033567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of serotonergic agents on neuroleptic induced catalepsy in rats.
    Rao SG; Hrishikeshavan HJ; Guruswami MN
    Funct Neurol; 1990; 5(4):353-60. PubMed ID: 1982664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcotic antagonist potentiation of L-DOPA in the reversal of reserpine induced catalepsy.
    Namba MM; Quock RM; Malone MH
    Proc West Pharmacol Soc; 1980; 23():285-9. PubMed ID: 7190698
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticataleptic effect of taurine: interaction with antiparkinsonian agents.
    Zebrowska-Lupina I; Porowska A
    Pol J Pharmacol Pharm; 1987; 39(4):329-35. PubMed ID: 2897118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
    Singh A; Naidu PS; Kulkarni SK
    Pharmacology; 2003 Jun; 68(2):81-8. PubMed ID: 12711835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats.
    Wardas J
    Pol J Pharmacol; 2003; 55(2):155-64. PubMed ID: 12926542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antihistaminics on cataleptogenic action of analgesics and haloperidol.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1983; 35(4):293-300. PubMed ID: 6141553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Facilitation of the effects of L-DOPA by alpha-methyldopa].
    Uspenskiĭ AE; Korobov NV
    Biull Eksp Biol Med; 1976 Mar; 81(3):314-6. PubMed ID: 986203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.